Seven partner institutes collaborate within DZIF at the Hanover - Brunswick site. The research fields "Hepatitis" and "Novel Antibiotics" are coordinated from here. The scientists aim to improve access to viral hepatitis therapies and conduct research on new diagnostic markers for courses of infection and therapy, amongst other things. The researchers also develop new approaches to effective treatment and control of resistant bacteria and investigate different molecular target sites for agents. Identifying and developing agent candidates that can be used as antibiotics play an important role.